Neurofibromatosis type 1 Trials in New York, United States
Conditions / Neurofibromatosis type 1 / New York, United States
Research into Neurofibromatosis type 1 spans multiple therapeutic approaches and trial phases.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01553149 | Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma | COMPLETED | PHASE2 |
| NCT03975829 | Pediatric Long-Term Follow-up and Rollover Study | ACTIVE_NOT_RECRUITING | — |
| NCT02415153 | Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors | COMPLETED | PHASE1 |
| NCT00352495 | Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma | COMPLETED | PHASE1 |
| NCT03190915 | Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT03871257 | A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00053937 | Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas | COMPLETED | PHASE1 |
| NCT06541847 | A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1 | RECRUITING | PHASE2 |
| NCT03975829 | Pediatric Long-Term Follow-up and Rollover Study | ACTIVE_NOT_RECRUITING | — |
| NCT03231306 | Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas | COMPLETED | PHASE2 |